Standout Papers

In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A ... 2022 2026 2023 2024161
  1. In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy (2022)
    M. Kim, Michaela Jeong et al. Science Advances
  2. Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications (2023)
    Michaela Jeong, Yeji Lee et al. Advanced Drug Delivery Reviews
  3. Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics (2023)
    Yeji Lee, Michaela Jeong et al. Experimental & Molecular Medicine

Immediate Impact

2 by Nobel laureates 22 from Science/Nature 68 standout
Sub-graph 1 of 23

Citing Papers

Rapid in silico directed evolution by a protein language model with EVOLVEpro
2024 StandoutScience
A Light‐Triggered J‐Aggregation‐Regulated Therapy Conversion: from Photodynamic/Photothermal Therapy to Long‐Lasting Chemodynamic Therapy for Effective Tumor Ablation
2024 Standout
1 intermediate paper

Works of Yeji Lee being referenced

In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy
2022 Standout

Author Peers

Author Last Decade Papers Cites
Yeji Lee 840 199 104 181 69 1.3k
Wenqing Chen 899 115 108 108 89 1.5k
Mengyun Li 609 345 88 102 97 1.3k
Bin Dong 544 129 115 77 69 1.0k
Souad R. Sennoune 972 129 169 84 57 1.7k
Xueyan Zhang 745 227 158 124 51 1.4k
Zhenglun Zhu 405 324 153 155 69 1.7k
Shannon Wing‐Ngor Au 924 236 47 125 36 1.5k
Saugata Hazra 931 151 123 118 72 1.7k
Xiaoling Xu 817 113 92 221 67 1.5k
Rong Wei 396 87 117 71 59 1.1k

All Works

Loading papers...

Rankless by CCL
2026